ProMIS™ Neurosciences, Inc.
The company’s scientific foundation centers on the growing knowledge base relating to diseases characterized by the presence of abnormal, misfolded proteins. Several neurodegenerative diseases exhibit protein misfolding, such as AD, ALS, and Parkinson’s disease (PD).